Sign in

CIK 0000939767

  • Large accelerated filer

EXELIXIS, INC.

Sign in to watch
Ticker
EXEL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Jan 1
Incorporated
DE
Entity type
Operating
EIN
043257395
Phone
+1 650-837-7000
Business address
1851 HARBOR BAY PARKWAY, ALAMEDA, CA, 94502
Former names
EXELIXIS INC
  1. 4 Grant or award CSO/EVP Disc & Trans Research acquired 132,819 shares (grant or award)
  2. 4 Grant or award EVP & General Counsel acquired 154,070 shares (grant or award)
  3. 4 Grant or award EVP, Commercial acquired 159,383 shares (grant or award)
  4. 4 Grant or award EVP and CFO acquired 170,009 shares (grant or award)
  5. 4 Planned sale EVP, Commercial sold 10,000 shares at $38.80 ($388,000)
  6. 4 Open-market sale Director sold 73,808 shares at an average $38.00 ($2,804,459)
  7. 4 Grant or award President and CEO acquired 184,909 shares (grant or award)
  8. 4 Grant or award CSO/EVP Disc & Trans Research acquired 49,209 shares (grant or award)
  9. 4 Grant or award EVP, Commercial acquired 47,718 shares (grant or award)
  10. 4 Grant or award EVP & General Counsel acquired 52,192 shares (grant or award)
  11. 4 Grant or award EVP Prod Dev & Med Aff & CMO acquired 52,192 shares (grant or award)
  12. 4 Planned sale Director sold 8,768 shares at $37.80 ($331,430)
  13. 4 Grant or award EVP and CFO acquired 59,648 shares (grant or award)
  14. 4 Open-market sale EVP, Commercial sold 52,636 shares at $36.98 ($1,946,479)
  15. 4 Open-market sale Director sold 18,647 shares at $37.25 ($694,601)
  16. 4 Open-market sale CSO/EVP Disc & Trans Research sold 26,987 shares at $36.75 ($991,772)
  17. 4 Gift President and CEO gave 177,985 shares (gift)
  18. 4 Open-market sale EVP and CFO sold 29,314 shares at $36.14 ($1,059,408)
  19. 4 Shares withheld for taxes EVP and CFO gave up 21,591 shares (to pay taxes)
  20. 4 Open-market sale Director sold 12,210 shares at an average $34.88 ($425,878)

Page 5 of 73 · 1,458 filings